Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics

BACKGROUND: Biosimilars provide safety, purity, and potency similar to those of a reference biologic product. METHODS: An array of protein analytical techniques was used to compare the physicochemical properties of proposed biosimilar filgrastim (EP2006), US-approved originator filgrastim, and EU-ap...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BioDrugs
Glavni autori: Sörgel, Fritz, Schwebig, Arnd, Holzmann, Johann, Prasch, Stefan, Singh, Pritibha, Kinzig, Martina
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2015
Teme:
Original Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4412827/
https://ncbi.nlm.nih.gov/pubmed/25837839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-015-0124-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items